Conclusions There was a positive trend over time in the proportion of women receiving MgSO 4 treatment, but the a priori target of 90% was not reached during the first year of implementation.
← all excerpts
A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth.
1
—
—